Related Experiment Video
Updated: May 15, 2026
09:33
Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
Published on: July 28, 2013
Differential cholinergic white matter microstructural alterations in multiple system atrophy and Parkinson's disease
Siming Rong1, Rui Yang1, Zihao Li2
1School of Medicine, South China University of Technology, Guangzhou 510006, China; Department of Neurology, Guangdong Neuroscience Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong Province, 510080, China.
Neurobiology of Disease
|May 13, 2026
Summary
Multiple system atrophy (MSA) shows greater microstructural damage in cholinergic pathways than Parkinson's disease (PD). The pedunculopontine nucleus (PPN)-thalamus pathway is most affected in MSA, aiding differential diagnosis.
Area of Science:
- Neuroscience
- Neuropathology
- Medical Imaging
Background:
- Multiple system atrophy (MSA) and Parkinson's disease (PD) are α-synucleinopathies with differing pathology.
- MSA involves more extensive white matter and cholinergic system degeneration than PD.
- The precise microstructural changes in cholinergic pathways for MSA and PD are not fully understood.
Purpose of the Study:
- To investigate and compare microstructural alterations in major cholinergic pathways in MSA and PD.
- To identify specific patterns of degeneration in these pathways.
- To evaluate the diagnostic potential of these alterations in differentiating MSA from PD.
Main Methods:
- Utilized probabilistic tractography to map NBM-cortex and PPN-thalamus pathways.
- Applied Free Water (FW) imaging to assess microstructural integrity in pathways and nuclei (NBM, PPN).
- Conducted voxel-wise analyses and Receiver Operating Characteristic (ROC) analysis for differentiation.
Main Results:
- MSA showed significantly higher FW in PPN-thalamus and NBM pathways compared to PD and controls.
- PD exhibited only mild FW elevations versus controls.
- FW was elevated in MSA's PPN compared to PD and controls; NBM showed similar elevations in MSA and PD versus controls.
- Voxel-wise analysis revealed widespread FW increases in MSA's cholinergic pathways, unlike PD.
- The PPN-thalamus pathway demonstrated the highest discriminatory power (AUC=0.786) between MSA and PD.
Conclusions:
- The PPN-thalamus pathway is selectively vulnerable in MSA, showing the most prominent FW increase.
- These findings suggest the PPN-thalamus pathway's potential utility in differentiating MSA from PD.
- Distinct microstructural degeneration patterns underscore the heterogeneity of cholinergic damage in α-synucleinopathies.
Related Concept Videos
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...